Correction to: Different effects of Î³-linolenic acid (GLA) supplementation on plasma and red blood cell phospholipid fatty acid composition and calcium oxalate kidney stone risk factors in healthy subjects from two race groups with different risk profiles pose questions about the GLA-arachidonic acid-oxaluria metabolic pathway: pilot study.

Rodgers, Allen L; Jappie-Mahomed, Dalielah; van Jaarsveld, Paul J

Rodgers, Allen L; Jappie-Mahomed, Dalielah; van Jaarsveld, Paul J.

Afiliação

Rodgers AL; Department of Chemistry, University of Cape Town, Rondebosch, Cape Town, 7701, South Africa. allen.rodgers@uct.ac.za.
Jappie-Mahomed D; Department of Chemistry, University of Cape Town, Rondebosch, Cape Town, 7701, South Africa.
van Jaarsveld PJ; Non-Communicable Diseases Research Unit (NCDRU), South African Medical Research Council, Cape Town, South Africa.

Urolithiasis ; 47(2): 215, 2019 04.

Article em En | MEDLINE | ID: mdl-30617640

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article